Indraprastha Medical Corporation Q2 Results FY27: PAT Rises 8.33% to Rs 53.58 Cr, Revenue Rs 412.85 Cr

Indraprastha Medical Corporation Ltd (INDRAMEDCO) Q2 Results FY27 announced on 29 October 2026, covering the company's financial performance for the July to September quarter. The results date brought standalone results with revenue of Rs 412.85 Cr and PAT of Rs 53.58 Cr, and Indraprastha Medical Corporation Q2 Results FY27 show revenue 8.35% higher than the same quarter last year on a Standalone basis.

Indraprastha Medical Corporation Q2 Results are examined here through a results analysis that covers the financial highlights, business drivers, outlook and risks. The figures below set out how revenue, Operating Profit and net profit moved against the same quarter last year, starting with the Financial Highlights table.

Click Here – Get Free Investment Predictions

Indraprastha Medical Corporation Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 412.85 Cr	Rs 381.03 Cr	+8.35% YoY
Operating Profit	Rs 77.44 Cr	Rs 71.31 Cr	+8.6% YoY
Net Profit (PAT)	Rs 53.58 Cr	Rs 49.46 Cr	+8.33% YoY

Source: company filing for Indraprastha Medical Corporation Q2 Results FY27, 29 October 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Indraprastha Medical Corporation Q2 Results: What Stands Out

• Revenue of Rs 412.85 Cr: sales grew 8.35% from Rs 381.03 Cr in the same quarter last year, a clear YoY growth figure.
• Net profit of Rs 53.58 Cr: PAT rose 8.33% from Rs 49.46 Cr, so net profit grew at almost the same pace as revenue.
• Operating Profit of Rs 77.44 Cr: this line increased 8.6% from Rs 71.31 Cr, the fastest of the three lines in Indraprastha Medical Corporation Q2 Results FY27.
• Quarter on quarter: net profit was down 4.1% from Rs 55.85 Cr in the previous quarter, which sits beside the yearly gain.
• Next step: the performance analysis below compares all three lines and notes what to track in later disclosures.

Indraprastha Medical Corporation Q2 Results FY27: Performance Analysis

Indraprastha Medical Corporation Q2 Results FY27 show a quarter in which revenue, Operating Profit and net profit all moved higher against the same quarter last year. Revenue reached Rs 412.85 Cr against Rs 381.03 Cr, a rise of 8.35%. Operating Profit rose to Rs 77.44 Cr, and net profit rose to Rs 53.58 Cr.

The results analysis shows YoY growth of 8.6% in Operating Profit, from Rs 71.31 Cr to Rs 77.44 Cr, alongside 8.33% growth in net profit from Rs 49.46 Cr to Rs 53.58 Cr. The supplied data confirms the movement but does not establish the specific cause, and Univest readers can compare all three lines across quarters.

For Indraprastha Medical Corporation Q2 Results, the three YoY growth rates sit within a narrow band of 8.33% to 8.6%. The quarterly results therefore leave investors watching whether revenue, Operating Profit and net profit keep moving together in the next filing, which is where the discussion turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points to four business factors, and the first is the top line. Revenue grew 8.4% year on year to Rs 412.85 Cr in the latest quarter, and this growth frames the Indraprastha Medical Corporation Q2 Results FY27 numbers.

Net Profit Growth – Net profit rose 8.3% year on year to Rs 53.58 Cr. This is the bottom line of the quarterly results, and it moved in step with revenue rather than ahead of it or behind it.

Return on Equity – Return on equity was 27.47% in FY26. This is a full-year measure that sits alongside the quarter and shows how efficiently the company used shareholder capital over the year.

Return on Capital Employed – Return on capital employed was 37.70% in FY26. This second full-year ratio complements the equity measure, and both lead directly into the outlook.

FY27 Outlook After Indraprastha Medical Corporation Q2 Results

The FY27 outlook after Indraprastha Medical Corporation Q2 Results depends on how the coming quarters build on this quarter. The results analysis records Operating Profit of Rs 77.44 Cr and net profit of Rs 53.58 Cr in Q2, and full-year FY27 results will depend on the quarters still to be reported.

Indraprastha Medical Corporation Q2 Results FY27 give investors a fixed reference for the next filing. The next disclosure will show how net profit moves from Rs 53.58 Cr and how revenue moves from Rs 412.85 Cr, and each new declaration can be followed on the Univest Screener, which brings the discussion to the risks.

Key Risks to Watch After Indraprastha Medical Corporation Q2 Results FY27

Quarter on Quarter Dip in Net Profit

Net profit was down 4.1% quarter on quarter from Rs 55.85 Cr. Indraprastha Medical Corporation Q2 Results FY27 therefore records a yearly gain beside a sequential dip, and YoY growth should be read together with the previous quarter.

Lower Return on Equity

Return on equity declined to 27.47% in FY26 from 29.97% in FY25. The ratio remains high in absolute terms, but the year on year decline is a measure to monitor as later quarters are reported.

Lower Return on Capital Employed

Return on capital employed declined to 37.70% in FY26 from 41.43% in FY25. Like the equity ratio, it is a full-year measure, and it gives context to the quarterly profit growth.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

In summary, Indraprastha Medical Corporation Q2 Results FY27 show revenue of Rs 412.85 Cr, Operating Profit of Rs 77.44 Cr and net profit of Rs 53.58 Cr in the quarterly results declared on 29 October 2026. The standalone results record steady YoY growth, and readers following Indraprastha Medical Corporation Q2 Results should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Indraprastha Medical Corporation Q2 Results FY27

What are Indraprastha Medical Corporation Q2 Results FY27?

Ans. Indraprastha Medical Corporation Q2 Results FY27 are the Standalone quarterly results for July to September 2026, with revenue of Rs 412.85 Cr and net profit of Rs 53.58 Cr. These figures appear in the Quick Answer and Financial Highlights.

What is the results date for Indraprastha Medical Corporation Q2 Results FY27?

Ans. Indraprastha Medical Corporation declared its results on 29 October 2026 for the July to September quarter. Alongside this, the results date marks the filing behind every figure here, as the introduction notes.

What revenue was reported in Indraprastha Medical Corporation Q2 Results FY27?

Ans. Indraprastha Medical Corporation Q2 Results FY27 report revenue of Rs 412.85 Cr, compared with Rs 381.03 Cr a year earlier. This means revenue rose 8.35%, as shown in the Financial Highlights table and Performance Analysis.

What net profit was reported in Indraprastha Medical Corporation Q2 Results FY27?

Ans. Net profit in Indraprastha Medical Corporation Q2 Results FY27 was Rs 53.58 Cr, compared with Rs 49.46 Cr a year earlier. This means PAT rose 8.33%, which the Key Takeaways section lists right after the revenue move.

How much YoY growth did revenue show in Indraprastha Medical Corporation Q2 Results FY27?

Ans. Revenue showed YoY growth of 8.35% in Indraprastha Medical Corporation Q2 Results FY27, moving from Rs 381.03 Cr to Rs 412.85 Cr. This sits alongside an 8.6% rise in Operating Profit, discussed in Performance Analysis.

Did net profit rise or fall in Indraprastha Medical Corporation Q2 Results?

Ans. Indraprastha Medical Corporation Q2 Results show net profit rising to Rs 53.58 Cr from Rs 49.46 Cr, a gain of 8.33%. So net profit grew along with revenue, as the Performance Analysis section explains in more detail.

What was the Operating Profit in Indraprastha Medical Corporation Q2 Results FY27?

Ans. Operating Profit in Indraprastha Medical Corporation Q2 Results FY27 was Rs 77.44 Cr, up 8.6% from Rs 71.31 Cr a year earlier. This is the fastest of the three YoY growth rates, as listed in Key Takeaways.

Are Indraprastha Medical Corporation Q2 Results standalone results or consolidated results?

Ans. Indraprastha Medical Corporation Q2 Results are standalone results, covering Indraprastha Medical Corporation Ltd on a Standalone basis for the July to September 2026 quarter. This is why every revenue and net profit figure in the article refers to standalone results.

What business factors shaped Indraprastha Medical Corporation Q2 Results FY27?

Ans. The business factors listed for Indraprastha Medical Corporation Q2 Results FY27 are 8.4% revenue growth, 8.3% net profit growth, a 27.47% return on equity and a 37.70% return on capital employed in FY26. Each is covered in Key Business Factors.

What are the key risks after Indraprastha Medical Corporation Q2 Results FY27?

Ans. The key risks after Indraprastha Medical Corporation Q2 Results FY27 are a 4.1% quarter on quarter dip in net profit and lower return ratios in FY26. These are set out in the Key Risks section, alongside the YoY growth figures.

What is the outlook after Indraprastha Medical Corporation Q2 Results?

Ans. The outlook after Indraprastha Medical Corporation Q2 Results rests on the coming quarters, with FY27 full-year results depending on later filings. This follows the Outlook section, which uses Q2 net profit of Rs 53.58 Cr as its reference point.

Where can I find the complete Indraprastha Medical Corporation Q2 Results FY27 data?

Ans. The complete Indraprastha Medical Corporation Q2 Results FY27 data sits in the Financial Highlights table of this article, which sets revenue, Operating Profit and net profit against the same quarter last year. Univest also keeps the company's stock page.